Drug Profile
Research programme: selective adrenergic reuptake inhibitors - Neurocrine
Alternative Names: Selective norepinephrine reuptake inhibitors - Neurocrine; SNRI - NeurocrineLatest Information Update: 24 Feb 2011
Price :
$50
*
At a glance
- Originator Neurocrine Biosciences
- Class
- Mechanism of Action Adrenergic uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain; Psychiatric disorders
Most Recent Events
- 02 Nov 2006 Preclinical trials in Pain in USA (unspecified route)
- 02 Nov 2006 Preclinical trials in Psychiatric disorders in USA (unspecified route)